| FFMMX | INUTX | FFMMX / INUTX | |
| Total Expense Ratio | 0.36 | 1.03 | 35% |
| Annual Report Gross Expense Ratio | 0.36 | 1.03 | 35% |
| Fund Existence | 6 years | 38 years | - |
| Gain YTD | 9.672 | 16.963 | 57% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 250 | 2000 | 13% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 118B | 2.54B | 4,644% |
| Annual Yield % from dividends | 1.65 | 2.19 | 75% |
| Returns for 1 year | 8.35 | 19.26 | 43% |
| Returns for 3 years | 34.77 | 41.79 | 83% |
| Returns for 5 years | 41.14 | 35.00 | 118% |
| Returns for 10 years | N/A | 48.43 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| LGHT | 8.20 | 0.04 | +0.49% |
| Langar Global HealthTech ETF | |||
| VABS | 24.09 | 0.05 | +0.21% |
| Virtus Newfleet Securitized Income ETF | |||
| BRNY | 58.87 | N/A | N/A |
| Burney U.S. Factor Rotation ETF | |||
| VGRO | 24.99 | N/A | N/A |
| VIRTUS SILVANT GROWTH OPPORTUNITIES ETF | |||
| XBI | 150.48 | -1.75 | -1.15% |
| State Street® SPDR® S&P® Biotech ETF | |||